Are migraine meds safe in pregnancy? new study seeks answers
NCT ID NCT05158894
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study watches pregnant women with migraines who take Ubrelvy or Qulipta, and compares them to pregnant women with migraines who don't take these drugs. Researchers will track the health of mothers and babies up to 12 months after birth. No new treatment is given—participants just take their prescribed medication as usual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Iqvia /Id# 266904
RECRUITINGDurham, North Carolina, 27703-8426, United States
-
Ottawa Hospital Research Institute /ID# 280174
RECRUITINGOttawa, Ontario, K1Y 4E9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.